Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding

Rev Invest Clin. 2015 Jan-Feb;67(1):15-9.

Abstract

Pharmacoperones are hydrophobic molecule drugs that enter cells and serve as a molecular framework to cause misfolded mutant proteins to fold properly and adopt a stable conformation compatible with proper intracellular trafficking. Pharmacoperones have successfully been used experimentally to rescue function of some misfolded proteins (enzymes, receptors, channels) that lead to disease. Identification of pharmacoperones by high-throughput screens of drug libraries will likely provide new molecules that may be potentially useful to treat diseases caused by protein misfolding.

MeSH terms

  • Animals
  • Drug Design
  • High-Throughput Screening Assays
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Chaperones / chemistry
  • Molecular Chaperones / metabolism*
  • Mutant Proteins / chemistry
  • Mutant Proteins / metabolism
  • Protein Folding
  • Proteins / chemistry
  • Proteins / metabolism*
  • Proteostasis Deficiencies / drug therapy*
  • Proteostasis Deficiencies / pathology

Substances

  • Molecular Chaperones
  • Mutant Proteins
  • Proteins